quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 18, 2026

Tom Lee Forecasts End Of Crypto Winter By This Month, Says Bitcoin, Ethereum May Find Support At These Levels

View original at finance.yahoo.com
Tom Lee Forecasts End Of Crypto Winter By This Month, Says Bitcoin, Ethereum May Find Support At These Levels Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Bitcoin might find support at $60,000

    80% confidence

  • Influential cryptocurrency traders have ruled out a sharp V-shaped recovery for Bitcoin, instead projecting a slow, grinding rebound

    80% confidence

  • The crypto winter could end as soon as April if it hasn't already

    80% confidence

  • Bitcoin could reach new all-time highs by early 2026

    80% confidence

  • Bitcoin might retrace to the $60,000–$65,000 range in early 2026

    80% confidence

  • Ethereum could bottom out at around $1,890

    80% confidence

  • The ongoing cryptocurrency winter is nearing its end, with Bitcoin and Ethereum close to hitting their lows

    80% confidence

  • Bitcoin's $60,000 low is the cycle bottom

    80% confidence

  • Ethereum touched the $1,890 support level to the penny and just needs to undercut it once more to establish the low

    80% confidence

  • Forecasted a 10-15% pullback in cryptocurrency prices in 2026 due to White House and Fed policy risks

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Tom Lee Forecasts End Of Crypto Winter By This Month, Says Bitcoin, Ethereum May Find Support At These Levels — Source | Via News | pt.VIA.NEWS